Polynovo Ltd (ASX: PNV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Polynovo Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.51 billion
P/E Ratio 856.00
Dividend Yield 0.00%
Shares Outstanding 690.23 million
Earnings per share 0.003
Dividend per share N/A
Year To Date Return 29.31%
Earnings Yield 0.12%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Polynovo Ltd (ASX: PNV)
    Latest News

    ⏸️ ASX Shares

    Why this fund manager believes PolyNovo shares are undervalued

    The PolyNovo Ltd (ASX:PNV) share price could be going a lot higher from here according to one fund manager. Here's…

    Read more »

    a woman
    Share Market News

    ASX 200 falls 0.9%, Afterpay share price hits new record

    The S&P/ASX 200 Index (ASX:XJO) fell by 0.9%. Despite that, the Afterpay Ltd (ASX:APT) share price hit a new all-time…

    Read more »

    watering can watering money trees which are growing in size
    Growth Shares

    Will Xero shares and these 2 other ASX companies be portfolio staples by 2030?

    Xero Limited (ASX: XRO) shares have clmbed higher in recent years but this is why it could be a share…

    Read more »

    crystal ball with bar graph inside, future share price, afterpay share price
    ⏸️ Growth Investing

    3 ASX 200 shares to buy and hold for decades

    ASX 200 shares have started to stabilise after a wild start to 2020 but where should you be investing for…

    Read more »

    Healthcare Shares

    2 ASX 200 biotech shares to consider buying today

    Aussie healthcare services are in demand this year, but which 2 ASX 200 biotech shares are trading for a bargain…

    Read more »

    Growth Shares

    Where next for the PolyNovo share price?

    The PolyNovo Ltd (ASX:PNV) share price could be on watch on Thursday after an insider sold shares. Should you be…

    Read more »

    Share Market News

    5 things to watch on the ASX 200 on Thursday

    Blackmores Limited (ASX:BKL) and PolyNovo Ltd (ASX:PNV) shares will be on watch on the ASX 200 on Thursday. Here's what's…

    Read more »

    3 piggy banks increasing in size, asx shares financials, growth, asx portfolio
    ⏸️ How to Invest

    3 easy rules for building a massive ASX share portfolio

    Here are 3 easy steps that you can use to build a massive ASX share portfolio for long-term wealth creation!

    Read more »

    Growing stack of coins on top of wooden blocks spelling out '2020', future wealth, asx future
    Growth Shares

    Where to invest $5,000 in ASX growth shares today

    A number of ASX growth shares have beaten the market in 2020. Check out a few of my favourites like…

    Read more »

    Healthcare Shares

    Got $2,000? Here are 2 ASX 200 healthcare shares to buy today

    If you've got $2,000 to invest but don't know what to buy, check out these 2 ASX 200 healthcare shares…

    Read more »

    Coronavirus News

    Here are all the ASX 200 shares that have doubled or more since the bottom of the bear market

    Almost 2 months on from the fastest bear market on record, here are all the S&P/ASX 200 shares that have…

    Read more »

    people building coins up over time, future wealth, asx future
    ⏸️ Shares to Watch

    $3,000 invested in these 3 ASX industries could make you a fortune in the future

    Here are 3 industries I think every future-minded ASX investor should be considering investing in today!

    Read more »

    Frequently Asked Questions

    The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was listed on the ASX  on 26 November 1998 and is headquartered in Melbourne.

    No, the company does not historically pay dividends.

    PNV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Polynovo Ltd

    PolyNovo Ltd (ASX: PNV) develops and commercialises innovative medical devices using its patented NovoSorb technology.

    NovoSorb is a family of biocompatible polymers that are used in the treatment of burns and surgical wounds. They biodegrade into by-products that can be absorbed and excreted by the body. For example, its NovoSorb BTM (Biodegradable Temporising Matrix) can be used to temporarily close a wound and aid the body in generating new tissue.

    PolyNovo’s products are sold across Australia and New Zealand, the United States, the United Kingdom, and Europe.

    PNV Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    27 Mar 2024 $2.14 $0.04 1.90% 1,793,957 $2.12 $2.22 $2.11
    26 Mar 2024 $2.10 $-0.02 -0.94% 6,338,523 $2.10 $2.12 $2.06
    25 Mar 2024 $2.12 $-0.01 -0.47% 2,646,839 $2.15 $2.16 $2.09
    22 Mar 2024 $2.13 $-0.07 -3.18% 1,118,356 $2.18 $2.19 $2.10
    21 Mar 2024 $2.20 $0.06 2.80% 2,071,350 $2.19 $2.24 $2.17
    20 Mar 2024 $2.14 $-0.05 -2.28% 1,883,237 $2.21 $2.25 $2.12
    19 Mar 2024 $2.19 $-0.16 -6.81% 2,478,168 $2.37 $2.39 $2.17
    18 Mar 2024 $2.35 $0.02 0.86% 1,183,680 $2.31 $2.36 $2.30
    15 Mar 2024 $2.33 $0.01 0.43% 2,641,536 $2.30 $2.35 $2.22
    14 Mar 2024 $2.32 $-0.17 -6.83% 2,344,276 $2.51 $2.51 $2.30
    13 Mar 2024 $2.49 $0.01 0.40% 1,851,249 $2.49 $2.52 $2.46
    12 Mar 2024 $2.48 $0.08 3.33% 3,173,551 $2.42 $2.52 $2.41
    11 Mar 2024 $2.40 $0.01 0.42% 1,306,415 $2.39 $2.44 $2.37
    08 Mar 2024 $2.39 $0.10 4.37% 3,030,795 $2.30 $2.41 $2.27
    07 Mar 2024 $2.29 $0.04 1.78% 1,609,829 $2.29 $2.30 $2.27
    06 Mar 2024 $2.25 $0.01 0.45% 1,564,337 $2.23 $2.26 $2.17
    05 Mar 2024 $2.24 $0.03 1.36% 1,531,840 $2.22 $2.25 $2.16
    04 Mar 2024 $2.21 $0.01 0.45% 2,194,703 $2.27 $2.30 $2.14
    01 Mar 2024 $2.20 $-0.08 -3.51% 2,227,886 $2.25 $2.25 $2.16
    29 Feb 2024 $2.28 $0.15 7.04% 3,585,967 $2.10 $2.28 $2.08
    28 Feb 2024 $2.13 $0.15 7.56% 6,081,790 $2.02 $2.19 $2.01
    27 Feb 2024 $1.99 $-0.03 -1.49% 1,765,142 $2.01 $2.03 $1.94

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 Oct 2023 Robyn Elliott Buy 32,000 $38,080
    On-market trade.
    28 Jun 2023 Robyn Elliott Buy 27,000 $39,690
    On-market trade.
    08 Jun 2023 David Williams Buy 22,500 $36,000
    On-market trade.
    07 Jun 2023 David Williams Buy 14,453 $23,448
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Williams Non-Executive DirectorNon-Executive Chairman Feb 2014
    Mr Williams was appointed as a Non-executive Director on 28 February 2014 and Chairman on 13 March 2014. Mr Williams is an experienced Director and investment banker with a track record in business development as well as in mergers and acquisitions and capital raising.
    Mr Bruce Rathie Non-Executive Director Feb 2010
    Mr Rathie was appointed a Director of PolyNovo on 18 February 2010. He is an experienced Company Director with a finance and legal background. He practised as a partner in a legal firm and acted as Senior Corporate Counsel to Bell Resources Limited.
    Dr Robyn Elliott Non-Executive Director Oct 2019
    Dr Elliott was appointed a Director of PolyNovo on 28 October 2019. Dr Elliott is currently Global Head, Strategic Portfolio Management at CSL Behring. Dr Elliott previously held Strategic Expansion and Quality Senior Director roles within CSL, was the Managing Director at IDT Australia and commenced her career at DBL Faulding.
    Mr Andrew Stuart Lumsden Non-Executive Director Jun 2021
    Mr Lumsden was appointed a Director of PolyNovo on 4 June 2021. He has more than 20 years' experience locally and internationally. Mr Lumsden is currently Chief Executive Officer of Wellcom Worldwide Australasia having previously held the roles of Group Chief Financial Officer and Group Chief Operating Officer.
    Mr Leon Hoare Non-Executive Director Jan 2016
    Mr Hoare was appointed a Director of PolyNovo on 27 January 2016. He is currently the Managing Director of Lohmann & Rauscher, Australia & New Zealand (ANZ), a private EU based medical device company. Previously he was Managing Director of Smith & Nephew ANZ (all divisions) until 2015. He served as President of Smith & Nephew's Asia-Pacific Advanced Wound Management (AWM) businesses for 5 years and was a member of the Global Executive Management for the AWM Division.
    Ms Christine Emmanuel-Donnelly Non-Executive Director May 2020
    Ms Emmanuel-Donnelly was appointed a Director of PolyNovo on 13 May 2020. She has more than 30 years' local and international experience. She is Vice President of the Board of the Institute of Patent and Trade Mark Attorneys of Australia on Springboard Enterprises Life Sciences Council, is a non-executive director on the board of Medical Developments International and is a member of the Australian Institute of Company Directors.
    Mr Jan-Marcel Gielen Chief Financial OfficerCompany Secretary Dec 2018
    -
    Mr Swami Raote Chief Executive Officer Jul 2022
    -
    Swami Raote Chief Executive Officer
    -
    Jan-Marcel Gielen Chief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 94,468,202 13.69%
    J P Morgan Nominees Australia Pty Limited 58,519,477 8.48%
    Citicorp Nominees Pty Limited 26,811,635 3.88%
    Moggs Creek Pty Ltd (Moggs Creek Super A/C) 19,010,112 2.75%
    BNP Paribas Noms Pty Ltd (Drp) 12,383,050 1.79%
    Lateral Innovations Pty Ltd (Trust A/C) 10,924,103 1.58%
    National Nominees Limited 8,413,960 1.22%
    Mr Anthony Shane Kittel + Mrs Michele Therese Kittel (Kittel Family Super A/C) 8,055,789 1.17%
    BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Drp) 5,909,896 0.86%
    Sandhurst Trustees Ltd (Endeavor Asset Mgmt Mda A/C) 5,739,049 0.83%
    Netwealth Investments Limited (Wrap Services A/C) 4,276,587 0.62%
    Ms Simone Maree Beks 4,185,095 0.61%
    Mr Paul Gerard Brennan 4,185,095 0.61%
    Commonwealth Scientific And Industrial Research Organisation 4,081,250 0.59%
    Mr Matthew James Avery 3,631,338 0.53%
    Mrs Li-Hsien Tsai 3,292,698 0.48%
    Mr David Kenley 3,139,855 0.45%
    Dr Marcus James Dermot Wagstaff + Mrs Lara Kate Wagstaff 3,072,166 0.45%
    Mr Laurent Fossaert 2,929,961 0.42%
    MR CHRIS DAWBORN (HASKALI SUPER FUND A/C) 2,870,271 0.42%

    Profile

    since

    Note